Repligen (RGEN) Short-term Investments (2011 - 2026)

Repligen's (RGEN) quarterly Short-term Investments came in at $201.9 million in Q1 2026, little changed on a QoQ basis from $201.6 million in Q4 2025.

Repligen (RGEN) Short-term Investments (2011 - 2026) Analysis & Trends

Repligen (RGEN) has 11 years of Short-term Investments data on file, last reported at $201.9 million in Q1 2026.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $201.9 million in Q1 2026; TTM through Mar 2026 was $201.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $201.6 million, changed N/A from the prior year.
  • Short-term Investments for Q1 2026 stood at $201.9 million, roughly flat from $201.6 million in the prior quarter.
  • Over the last five years, Short-term Investments for RGEN reached as high as $201.9 million in Q1 2026 and fell as low as $100.3 million in Q4 2022.
  • Historically, Short-term Investments has averaged $151.3 million across 4 years, with a median of $151.5 million in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.15 Bn 120.94 Bn 1.96 Bn
2 Becton Dickinson 44.73 Bn 43.91 Bn 2.15 Bn
3 Alcon 32.91 Bn 31.25 Bn 1.53 Bn
4 Medline 32.79 Bn 30.55 Bn 1.84 Bn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn
6 West Pharmaceutical Services 23.52 Bn 23.08 Bn 329.20 Mn
7 Solventum 14.04 Bn 13.47 Bn 1.10 Bn
8 Cooper Companies 13.78 Bn 13.64 Bn 735.40 Mn
9 Align Technology 12.04 Bn 10.98 Bn 736.59 Mn
10 Repligen 7.36 Bn 6.37 Bn 108.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 201.88 Mn
Dec 31, 2025 201.61 Mn
Mar 31, 2023 101.41 Mn
Dec 31, 2022 100.30 Mn
Jun 30, 2017 2.74 Mn
Mar 31, 2017 12.18 Mn
Dec 31, 2016 19.55 Mn
Sep 30, 2016 21.06 Mn
Jun 30, 2016 9.18 Mn
Mar 31, 2016 16.48 Mn
Dec 31, 2015 17.68 Mn
Sep 30, 2015 20.79 Mn
Jun 30, 2015 23.15 Mn
Mar 31, 2015 23.26 Mn
Dec 31, 2014 23.09 Mn
Sep 30, 2014 18.17 Mn
Jun 30, 2014 16.27 Mn
Mar 31, 2014 21.55 Mn
Dec 31, 2013 21.79 Mn
Sep 30, 2013 20.75 Mn